Novanta (NASDAQ:NOVT) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Novanta (NASDAQ:NOVT) from a hold rating to a buy rating in a research note published on Saturday morning.

NOVT has been the topic of several other research reports. Weiss Ratings upgraded shares of Novanta from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Tuesday, January 20th. Zacks Research upgraded shares of Novanta from a “strong sell” rating to a “hold” rating in a research note on Friday, January 16th. Finally, Robert W. Baird upgraded shares of Novanta from a “neutral” rating to an “outperform” rating and lowered their price objective for the stock from $150.00 to $144.00 in a research note on Monday, March 30th. One investment analyst has rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $144.00.

Novanta Price Performance

Shares of NASDAQ:NOVT opened at $116.91 on Friday. The firm’s 50 day moving average price is $130.84 and its 200-day moving average price is $121.43. Novanta has a twelve month low of $98.27 and a twelve month high of $149.95. The company has a quick ratio of 2.80, a current ratio of 3.69 and a debt-to-equity ratio of 0.16. The stock has a market capitalization of $4.17 billion, a PE ratio of 80.08 and a beta of 1.64.

Novanta (NASDAQ:NOVT) last issued its quarterly earnings data on Monday, February 23rd. The technology company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.88 by $0.03. Novanta had a net margin of 5.49% and a return on equity of 13.12%. The firm had revenue of $258.35 million for the quarter, compared to analysts’ expectations of $260.72 million. During the same quarter in the prior year, the business earned $0.76 EPS. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q1 2026 guidance at 0.750-0.800 EPS. Equities research analysts expect that Novanta will post 3.03 EPS for the current year.

Insider Buying and Selling

In other Novanta news, CFO Robert Buckley sold 9,957 shares of the firm’s stock in a transaction that occurred on Monday, March 16th. The shares were sold at an average price of $116.77, for a total transaction of $1,162,678.89. Following the sale, the chief financial officer owned 96,616 shares in the company, valued at approximately $11,281,850.32. This trade represents a 9.34% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Matthijs Glastra sold 7,500 shares of the firm’s stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $145.04, for a total transaction of $1,087,800.00. Following the sale, the chief executive officer owned 57,367 shares in the company, valued at approximately $8,320,509.68. The trade was a 11.56% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 34,303 shares of company stock worth $4,545,416. 1.20% of the stock is owned by company insiders.

Institutional Investors Weigh In On Novanta

A number of institutional investors and hedge funds have recently added to or reduced their stakes in NOVT. Pilgrim Partners Asia Pte Ltd bought a new stake in Novanta during the 3rd quarter worth approximately $36,000. Migdal Insurance & Financial Holdings Ltd. bought a new stake in Novanta during the 3rd quarter worth approximately $40,000. Danske Bank A S bought a new stake in Novanta during the 3rd quarter worth approximately $40,000. Allworth Financial LP raised its stake in Novanta by 978.4% during the 4th quarter. Allworth Financial LP now owns 399 shares of the technology company’s stock worth $47,000 after acquiring an additional 362 shares during the period. Finally, EverSource Wealth Advisors LLC grew its holdings in Novanta by 120.1% during the 4th quarter. EverSource Wealth Advisors LLC now owns 427 shares of the technology company’s stock valued at $51,000 after buying an additional 233 shares in the last quarter. Institutional investors own 98.35% of the company’s stock.

Novanta Company Profile

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.